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Abstract
Background: The opportunistic enterobacterium, Morganella morganii, which can cause bacteraemia, is the ninth
most prevalent cause of clinical infections in patients at Changhua Christian Hospital, Taiwan. The KT strain of
M. morganii was isolated during postoperative care of a cancer patient with a gallbladder stone who developed
sepsis caused by bacteraemia. M. morganii is sometimes encountered in nosocomial settings and has been causally
linked to catheter-associated bacteriuria, complex infections of the urinary and/or hepatobiliary tracts, wound
infection, and septicaemia. M. morganii infection is associated with a high mortality rate, although most patients
respond well to appropriate antibiotic therapy. To obtain insights into the genome biology of M. morganii and the
mechanisms underlying its pathogenicity, we used Illumina technology to sequence the genome of the KT strain
and compared its sequence with the genome sequences of related bacteria.
Results: The 3,826,919-bp sequence contained in 58 contigs has a GC content of 51.15% and includes 3,565
protein-coding sequences, 72 tRNA genes, and 10 rRNA genes. The pathogenicity-related genes encode
determinants of drug resistance, fimbrial adhesins, an IgA protease, haemolysins, ureases, and insecticidal and
apoptotic toxins as well as proteins found in flagellae, the iron acquisition system, a type-3 secretion system (T3SS),
and several two-component systems. Comparison with 14 genome sequences from other members of
Enterobacteriaceae revealed different degrees of similarity to several systems found in M. morganii. The most
striking similarities were found in the IS4 family of transposases, insecticidal toxins, T3SS components, and proteins
required for ethanolamine use (eut operon) and cobalamin (vitamin B12) biosynthesis. The eut operon and the gene
cluster for cobalamin biosynthesis are not present in the other Proteeae genomes analysed. Moreover, organisation
of the 19 genes of the eut operon differs from that found in the other non-Proteeae enterobacterial genomes.
Conclusions: This is the first genome sequence of M. morganii, which is a clinically relevant pathogen.
Comparative genome analysis revealed several pathogenicity-related genes and novel genes not found in the
genomes of other members of Proteeae. Thus, the genome sequence of M. morganii provides important
information concerning virulence and determinants of fitness in this pathogen.
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Background
The Gram-negative anaerobic rod Morganella morganii
is the only species in the genus Morganella, which
belongs to the tribe Proteeae of the family Enterobacter-
iaceae. The other genera in the tribe Proteeae are Proteus
and Providencia. Species belonging to Morganella, Pro-
teus, and Providencia are found in the environment and
as part of the normal flora of humans. They are also
important opportunistic pathogens, which cause a wide
variety of nosocomial infections following surgery.
Reports of individual cases of infection and nosocomial-
outbreaks have revealed that infection with M. morganii
can lead to major clinical problems, which are usually
associated with common causes of catheter-associated
bacteriuria, infections of the urinary and hepatobiliary
tracts [1-5], wound infection, and septicaemia [6-9].
A few devastating infections with M. morganii that were
associated with a high mortality rate following bacterae-
mia sepsis and/or nosocomial infection have also been
reported, although most of such infections respond well
to appropriate antibiotic therapy [3,10-13].
Although M. morganii was formerly classified as Proteus
morganii [14], it was later assigned to the genus Morga-
nella on the basis of DNA-DNA hybridisation results [15].
Members of the genus can ferment trehalose, and express
lysine decarboxylase and ornithine decarboxylase [16].
Like other members of the Enterobacteriaceae,
M. morganii has a natural resistance to b-lactam anti-
biotics [17]. Many strains of M. morganii are resistant
to the drugs cefazolin, cefixime, cefpodoxime, and ampi-
cillin [1,2,18,19]. Members of the tribe Proteeae, which
include Proteus, Providencia and M. morganii share
homologous genes acquired from horizontal gene trans-
fer via conjugative integration or mobile transposition
[20-25]. The drug resistance of M. morganii was intro-
duced via extra genetic elements [26,27] and/or mobile
elements [23,24]. The resistant strains that carry blaCTX-M
gene are capable of producing b-lactamases [28], which
can break down the extended spectrum b-lactam drugs
[29].
Complicated urinary tract infections, especially those
associated with long-term catheterisation may be caused
by polymicrobes, as well as biofilm formation. In addition
to M. morganii, Escherichia coli, P. mirabilis, Providencia
stuartii, Klebsiella pneumoniae, and Pseudomonas aerugi-
nosa frequently cause urinary tract infections [2,30,31].
Like P. mirabilis, M. morganii is motile, with peritrichous
flagellar. The flagella-encoding genes are located in a con-
tiguous manner in a single locus of the P. mirabilis genome
[32]. Besides flagella, adherence is another major determi-
nant of bacterial colonisation and biofilm formation. Sev-
eral fimbriae have also been shown to play important roles
in establishing complicated urinary tract infections [33-37].
They are type-1 fimbriae, mannose-resistant/Proteus-like
(MR/P) fimbriae, uroepithelial cell adhesin (UCA; also
called NAF for nonagglutinating fimbriae), type-3 fimbriae,
and P. mirabilis fimbriae (PMF; also called MR/K).
The production of urease has a fitness factor that influ-
ences bacterial growth and biofilm formation during urin-
ary tract infections. Other virulence factors may include
iron acquisition systems, type-3 secretion system (T3SS),
two-component systems (TCS), proteins that function in
immune evasion (IgA protease), and haemolysins [35].
The environment found in the guts of nematodes or
insects may be an important determinant of bacterial
pathogenicity [38]. Ethanolamine, which is abundant in
human diets and the intestinal tracts of humans, can be
used by gut bacteria as a source of carbon and/or nitrogen
[39]. The association between the use of ethanolamine and
the virulence of various pathogens has been reported [39].
Phylogenetic assessment of 16S rRNA sequences indi-
cates that P. mirabilis is the closest relative of M. morganii.
Only one complete Protues genome sequence and four
draft sequences of Providencia spp. are available.
Here we report the draft genome sequence of a clinical
isolate of M. morganii and the results of its bioinformatic
analysis to enhance understanding of M. morganii biology.
Comparative analysis of the sequences with the sequences
of other Proteeae and Enterobacteriaceae genomes identi-
fies potential virulence determinants, which may provide
new drug targets.
Results
Epidemiological study of M. morganii infection
Over a 6-year period (2006-2011), samples were collected
from all patients at Changhua Christian Hospital, Taiwan,
who presented with symptoms of Gram-negative bacterial
infections. Of 82,861 samples, 1,219 (1.47%) were positive
for M. morganii and 3,503 (4.23%) were positive for
Proteus spp. As shown in Table 1, M. morganii was ranked
between the eighth and fourteenth most prevalent Gram-
negative bacterial species isolated from the hospital over
12 consecutive 6-month intervals during the 6 years of the
study.
The KT strain of M. morganii was isolated from the
blood of a patient who developed sepsis during post-
operative care. The KT strain was found to be suscepti-
ble to amikacin, ertapenem, gentamicin, meropenem,
and cefepime but resistant to ampicillin, amoxicillin-
clavulanate, cefazolin, cefuroxime, cefmetazole, flomoxef,
and cefotaxime.
General features of the M. morganii draft genome
The genome of the M. morganii strain KT, which carries
no plasmids, was assembled de novo into 58 contigs (each
>200 bp long), which together comprised 3,826,919 bp
with a GC content of 51.15%. The largest contig is 410,849
bp long, and the N50 statistic (the minimum contig length
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of at least 50% of the contigs) is 240,446 bp, with pair-end
short read sequencing coverage >1,150-fold. Seven small
contigs (each <13 kb) had low-depth reads (0.36- to 0.66-
fold), whereas two pairs and one triad shared high
sequence identity with minor differences at their ends
(Additional file 1). The origin of replication assigned on
the basis of the GC-skew analysis together with the loca-
tion of the dnaA gene and DnaA boxes of the genome lies
between gidA (MM01685) and mioC (MM01686) (Addi-
tional File 1: Figure S1).
As shown in Table 2, comparison of the M. morganii
sequences with the complete genome of P. mirabilis
HI4320 revealed a 12.2% difference in GC-content of
the two species (51.1% for M. morganii vs. 38.9% for
P.mirabilis).
Sequences that encode eight 5S rRNAs, one 16S rRNA,
and one 23S rRNA were identified using the ribosomal
RNA scan application in RNAmmer (http://www.cbs.dtu.
dk/services/RNAmmer/) (Table 2). Further analysis of
contigs revealed that the 16S rRNA had a read depth of
7.9-fold and that the 23S rRNA had a read depth of 8.2-
fold (Additional file 2: Supplementary table 1).
Coding DNA sequences
Database searches identified 3,565 predicted coding
sequences (CDSs). Among them, 2,870 CDSs could be
placed into clusters of orthologous groups with assigned
biological functions (Figure 1). The proteins annotated as
pathogenicity and fitness factors are listed in Table 3, with
additional information in Tables 4, 5, 6 and Additional
Files 3, 4, 5, 6, 7, 8: Supplementary tables 2-7.
Prophages and mobile elements
Bacteriophages and transposons, which may contribute
to genome plasticity [40], are, in general, laterally
acquired elements [32]. In the M. morganii genome, 2
prophages (MM3229 through MM3271 and MM2276
through MM2290) and 12 degenerate prophages together
comprise 236 prophage-related genes (Additional file 9:
Supplementary table 8). The prophage 1 genes were also
found in the genome of Proteus mirabilis, Providencia
alcalifaciens, and Providencia rustigianii, whereas the
prophage 2 genes are orthologous to those found in the
other 14 Enterobacteriaceae genomes.
Neither the integrated conjugative element ICEPm1
(reported in certain M. morganii strains and P. mirabilis
[30]) nor ICE/R391 (reported in Providencia spp. and
P. mirabilis [24]) was found in M. morganii strain KT.
However, several integrase recognition sequences, includ-
ing prfC (MM1941) and two tRNA PheV sites (contig 1:
376,829 - 376,904 bp and contig 12: 37,047-37,122 bp), are
present in the strain KT genome.
Drug resistance
A chromosomally encoded b-lactamase from M. morga-
nii has been cloned [41]. The clinical strains with high or
low levels of cephalosporinase expression were found to
harbour the adjacent ampC (MM3167) and ampR






























Escherichia coli 1 1 1 1 1 1 1 1 1 1 1 1 24,698 1
Pseudomonas
aeruginosa
2 2 2 2 2 2 2 2 2 3 4 3 13,390 2
Klebsiella
pneumoniae
3 3 3 3 3 3 3 3 3 2 3 2 10,902 3
Haemophilus
influenzae
4 5 4 5 4 4 4 4 4 5 2 5 7,124 4
Acinetobacter
baumannii complex
5 4 5 4 5 5 5 7 5 4 5 4 4,927 5
Proteus mirabilis 7 6 6 6 7 6 7 5 6 6 6 6 3,324 6
Enterobacter cloacae 6 7 7 7 8 8 8 6 7 7 7 7 2,794 7
Stenotrophomonas
maltophilia
8 10 10 10 11 10 12 12 9 9 9 10 1,538 8
Morganella
morganii
12 11 14 13 10 12 13 17 12 8 10 13 1,219 9
Serratia marcescens 11 14 13 16 14 16 14 13 11 13 11 12 1,061 10
Salmonella group B 15 15 19 15 18 13 20 11 17 12 17 9 873 11
Salmonella enteritidis
group D
21 19 20 18 NA 18 15 15 13 11 13 11 706 12
The frequency of infection by 21 bacterial species was monitored over 6-month intervals (the first and second halves of each year) and ranked such that 1
denotes the species most frequently associated with bacterial infection. The column heading ‘# infections’ represents the total number of patients infected with
the species indicated. NA: data not available, not significant to the ranking list.
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(MM3166) genes, which are flanked by the hybF and
orf-1 genes [17]. The ampC and ampR genes produce
both broad-spectrum and the ampC b-lactamases or only
the ampC b-lactamase [42]. In Providencia spp., the
production of metallo-b-lactamases has been associated
with resistance to carbapenems [43,44]. The M. morganii
KT strain also contains the gene encoding b-lactamase,
which confers resistance to aminopenicillins. Genes that
Table 2 Genome analysis of M. morganii KT and P. mirabilis HI4320
Feature Morganella morganii KT contigs Proteus mirabilis HI4320 chromosome
Genome 58 None
Contig numbers 240,446 None
N50 contig size (bp) 3,826,919 4,063,606
Total contig length (bp) 51.15 38.9
Protein-coding genes
No. of predicted genes 3,565 3,607
CDS with assigned to COGs 2,870 2,850




23S rRNA 1(~7.9X) 7
16S rRNA 1(~8.2X) 7
5S rRNA 8 8
The draft genome of M. morganii strain KT were de novo assembled into 58 contigs (length > 200 bp), the N50 contig size is 240,446 bp, (N50: the minimum
contig length of at least 50% of the contigs), which together comprised 3,826,919 bp with GC content of 51.15%. P. mirabilis HI4320 chromosome has total
4,063,606 bp and G+C content of 38.9% [32].
Database searches identified 3,565 predicted coding sequences (CDSs). Among them, 2,870 CDSs could be placed into clusters of orthologous groups with
assigned biological functions, and 21 transposes have also predicted. As P. mirabilis identified 3,607 predicted CDSs, 2,850 could placed into clusters of
orthologous groups and have 33 transposes predicted.
M. morganii have predicted 72 tRNAs, as P. mirabilis have 83 tRNAs. M. morganii have one 16S rRNA, one 23 SrRNA, and eight 5S rRNA were predicted, Further









J A K L D V T M N U O C G E F H I P Q R S 
Morganella morganii 
Proteus mirabilis 
Figure 1 Compare functional category of in silico predicted proteins. Functional category of in silico predicted proteins. The colors used in the
bars represent different object: blue, Morganella morganii KT; red, Proteus mirabilis HI4320. Proteins were clustered by COG assignment: [1]
Information storage and processing: (J) translation, ribosomal structure and biogenesis; (A) RNA processing and modification; (K) transcription;
(L) replication, recombination and repair; [2] Cellular processes and signalling: (D) cell cycle control, cell division, chromosome partitioning;
(V) defense mechanisms; (T) signal transduction mechanisms; (M) cell wall/membrane/envelope biogenesis; (N) cell motility; (U) intracellular
trafficking, secretion, and vesicular transport; (O) posttranslational modification, protein turnover, chaperones; [3] Metabolism: (C) energy production
and conversion; (G) carbohydrate transport and metabolism; (E) amino acid transport and metabolism; (F) nucleotide transport and metabolism;
(H) coenzyme transport and metabolism; (I) lipid transport and metabolism; (P) inorganic ion transport and metabolism; (Q) secondary metabolites
biosynthesis, transport and catabolism; [4] Poor characterized: (R) general function prediction only; (S) function unknown.
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encode three metallo-b-lactamases (MM2254, MM2308,
and MM2606) were found. Moreover, the M. morganii
genome also encodes the tetracycline resistant protein
TetAJ (MM3521) and the chloramphenicol acetyltrans-
ferase CatA2 (MM3053).
Other drug resistance genes include a tellurite resistance
operon (MM0993 through MM1004), the bicyclomycin
(sulphonamide) resistance gene bcr (MM2780), a catB3-
like putative acetyltransferase gene (MM0469), and a kasu-
gamycin resistance gene ksgA (MM2040). The tellurite
resistance ter operon was also identified in P. mirabilis
HI4320, P. stuartii ATCC# 25827, K. pneumoniae NTUH
K2044, E. coli O157:H7, and E. coli APEC O1. The genes
involved in multidrug efflux and the CDSs predicted to
Table 3 Pathogenicity and fitness factors identified from analysis of the genome of M. morganii KT
Category Niche genes of M. morganii KT
Drug resistance Ampicillin resistance, ampC-ampR.
Metallo-b-lactamases (MBL) MM2254, MM2308, and MM2606.
Tellurite resistance operon MM933-1004.
Tetracycline resistant, chloramphenicol, acetyltransferase, bicyclomycin, acetyltransferase,
kasugamycin tetAJ, catA2, bcr, catB3-like, ksgA.
Multidrug resistance and efflux genes (34 genes, Additional File 3: Supplementary table 2).
Fimbrial adhesins 3 MR/P operons, 13 mrpJ paralogous, 1 fimbrial chaperone, 2 UCA (NAF) operons, 1 PMF operon,
and 2 other operons (Tables 4, 5).
6 putative type IV pili genes hofCB, ppdABCD, and 2 putative trimeric autotransporter secretion
genes MM2011, MM2042.
Motility/flagellum-related Most flagellum-related genes and chemotaxis genes; MM1735-1785, MM1796-1797, and MM1786-
1793 (at a single locus) (Additional File 4: Supplementary table 3).
Methyl-accepting chemotaxis gene MM0264, aerotaxis gene MM1607, and 9 regulators of flagellar
genes umoABCD, rssBA, rcsBCD.
T3SS Type III secretion system needle complex MM0224-MM0243 (20 genes), and effectors, ipaCBD-
chaperone (MM0244-MM0247, 4 genes) (Additional File 5: Supplementary table 4)
TCS 19 potential two-component regulator systems (TCS) were identified.
Iron acquisition system Heme uptake, ferric, ferrous iron transport, ferric siderophore receptor, B12 transporter, and
siderophore iron uptake hmuSTUV, afuABC, feoAB, ireA, btuCD, btuB, and yfeDCBA
18 other related genes (fecR, ABC transporters, TonB-dep. receptors)
IgA protease Zinc metalloprotease, capable of cleaving host Ig, zapABCD (MM1054-MM1056, MM1058)
LPS, ECA & capsule (1) Release lipid A, induce initial endotoxic shock and enterobacterial common antigen (41 genes,
Additional File 6: Supplementary table 5) (2) Protect from phagocytosis, rcsB,C,D,F
Haemolysins hmpBA (MM2452, MM2453)
Ureases Urea as a nitrogen source, rapid urea hydrolysis, a cause of stone formation. ureABCEFGD-urea
transporter (MM1961-MM1968)
Insecticidal& apoptotic toxins 9 insecticidal toxin: (1) tccB, tccA, and tcdB2 (MM0965-MM0967), (2) xptA1A1C1 (MM1780-1782), (3)
tcaC, tccB3, and tcaC (MM1901, MM2567 and MM2570) (Additional File 7: Supplementary table 6)
RtxA, XaxAB, intimin/invasion, HlyD toxin secretion, toxin transporter
Other genes required for persistence of
infection and fitness for infection
6 superoxide stress genes katA, soxS, sodC,B,A, oxyR (Additional File 8: Supplementary table 7)
The phage-shock-protein, pspABC operon (MM0627-MM0629)
Ethanolamine utilisation Ethanolamine utilisation system, provide carbon and/or nitrogen uptake;
eutSPQTDMNEJGHABCLK-pduST-eutR (MM1148-MM1130). (Table 6)
Cobalamin biosynthesis Cobalamin (vitamin B12) biosynthesis, cbi-cob operon MM1167-MM1187.







MM2683-MM2686 pmf (P. mirabilis fimbria); also called MR/K
MM2740-MM2745 uca (uroepithelial cell adhesin); also called naf (nonagglutinating fimbria
MM2839-MM2842 Fimbria 8
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confer antimicrobial resistance are listed in Additional file
10: Supplementary table 9.
Fimbriae, pili, and adhesion proteins
As shown in Table 4, eight potential chaperone-usher
fimbrial operons were identified. Among them, three
were previously identified as the operons that encode
the components of the MR/P, UCA (NAF), and PMF
(MR/K) fimbriae [33,34]. An apparent duplicate of the
mrp operon immediately adjacent to mrpJ was desig-
nated mrp’ (Figure 2). This is similar to the duplicated
operon present in P. mirabilis, albeit with different
annotation and orientation of the constituent genes [32].
Interestingly, the M. morganii genome contains 13 para-
logues of mrpJ, which encodes a transcriptional regula-
tor that represses motility [45]. As shown in Table 5,
two mrpJ genes were associated with each of the fim-
brial operons.
Together with the hofC (MM3190) and hofB (MM3191)
genes, four genes, namely ppdA (MM2057), ppdB
(MM2058), ppdC (MM2060), and ppdD (MM3192), are
involved in the assembly of type-IV pili. Two genes that
encode putative trimeric autotransporter adhesins
(MM2011 and MM2242) are homologues of proteins
found in P. stuartii ATCC# 25827 and Y. enterocolitica
8081.
Motility and chemotaxis systems
Fifty three genes that encode proteins required for fla-
gellar structure (MM1735 through MM1785, as well as
MM1796 and MM1797) and eight chemotaxis-related
genes (MM1786 through MM1793, including cheA,
cheW, cheD, tap, cheR, cheB, cheY, and cheZ) are con-
tained in the M. morganii genome. With the exception
of the genes that encode two LysR family transcriptional
regulators (MM1739 and 1765), the camphor resistance
protein CrcB and related genes (MM1743 through
MM1749), a short-chain dehydrogenase/reductase SDR
(MM1764), and the three insecticidal toxin complex
proteins encoded by xptA1A1C1 (MM1780 through
MM1782), the organisation of flagellar genes is similar
to that of P. mirabilis.
The genes that flank the locus that encodes flagellar
structural proteins encode a methyl-accepting chemotaxis
protein (MM0264) and an aerotaxis protein (MM1607).
Genes that encode regulators of flagellar motility, such as
umoA (MM1647), umoB (MM3381), umoC (MM1924),
umoD (MM2830), rssBA (MM2256 and MM2257), and
the rcsBCD phosphorelay regulatory system (MM1705
through MM1707), were also identified.
Iron acquisition
The M. morganii genome encodes the hmuSTUV haeme
uptake system (MM0575 through MM0578), the afuABC
system for ferric and ferrous iron transport (MM1068
through MM1070), feoAB (MM2728 and MM2729), the
ferric siderophore receptor locus ireA (MM3404), the B12
transporter locus btuCD (MM0560 and MM0561), btuB
(MM2756), and the siderophore iron uptake systems
yfeDCBA (MM0546 through MM0549) to circumvent host
Table 5 mrpJ paralogues in M. morganii














Table 6 Protein similarity search of ethanolamine
utilization (eut) operon of M. morganii
eut genes
eutS Eco (85%) Eb(84%) Ko(84%)
eutP Eco (67%) Ss(66%) Sb(66%)
eutQ Se (63%) Ko(63%) Yi(63%)
eutT Eco (65%) Ko(65%) Yi(64%)
eutD Eco (72%) Ko(70%) Yi(69%)
eutM Yi (96%) Eco(94%) Ecl(94%)
eutN Yi (84%) Cy(74%) Ecl(74%)
eutE Ck (78%) Eco(77%) Yi(76%)
eutJ Yi (73%) Eco(71%) Cy(70%)
eutG Yi (67%) Ko(59%) Se(58%)
eutH Yi (82%) Cy(80%) Yr(80%)
eutA Yi (76%) Pa(70%) Cy(67%)
eutB Yi (85%) Cy(85%) Yr(85%)
eutC Eco (78%) Ko(77%) Ecl(77%)
eutL Cy (87%) Se(85%) Ecl(85%)
eutK Eco (56%) Se(53%) Cy(51%)
pduS Ha (66%) Yi(66%) Eb(65%)
pduT Ta (63%) Yi(63%) Eb(63%)
eutR Yi (62%) Ko(56%) Eco(56%)
M. morganii has longest ethanolamine utilization (eut) operon,
eutSPQTDMNEJGHABCLK-pduST-eutR which consists of 19 genes.
The two novel genes in eut of M. morganii KT, pduT and pduS, were found
orthologous protein from pdu operon from other species. Sequence identity
of best top three hits ranging from 51 to 87% and species were varied.
Abbreviation of species were Eco: Escherichia coli; Eb: Enterobacteriaceae
bacterium; Ko: Klebsiella oxytoca; Ss: Shigella sonnei; Sb: Shigella boydii; Se:
Salmonella enterica; Yi: Yerisinia intermedia; Yr: Yokenella regensburgei; Ecl:
Enterobacter cloacae; Cy: Citrobacter youngae; Ck: Citrobacter koseri; Ta:
Tolumonas auensis; Ha: Hafnia alvei; Pa: Photorhabdus asymbiotica. Id (%)
represent percent of identify compare two orthologous proteins.
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iron-sequestering mechanisms. A possible haeme-binding
system is encoded by MM1650 and MM1651. A gene that
encodes a putative iron receptor (MM1952) is located adja-
cent to a fecR homologue (MM1953). There are two other
iron-related ABC transporters (encoded by MM2795 and
MM2796, and MM0258 through MM0260) and 12 addi-
tional TonB-dependent receptors (encoded by MM0169,
MM0255, MM1275, MM1299, MM1650, MM1872,
MM1952, MM2348, MM2405, MM2430, MM2542, and
MM2798).
Zinc acquisition
The znuACB high-affinity zinc transporter system was
recently shown to be a fitness factor for E. coli and
P. mirabilis during experimental urinary tract infection
[46,47]. The system is encoded by M. morganii gene pro-
ducts MM2146 through MM2148.
Type III secretion system
A T3SS, which comprises gene products MM0224
through MM0247 and has a low GC-content (43.7%),
resides in a 20.8-kb pathogenicity island. This island of 24
genes, which shares homologous syntenic blocks with
P. mirabilis [48], contains all the components needed to
assemble a T3SS needle complex. Except for the genes
that encode effector proteins, the most homologous pro-
teins were orthologues from P. mirabilis (Additional
File 5: Supplementary table 4). A putative IpaCBD operon,
which encodes chaperones for three proteins (MM0244
through MM0247) was also found. The IpaC and IpaD
proteins have low similarity (21% and 38%, respectively) to
those of P. mirabilis, whereas the IpaB protein has the
highest homology with ipaB of P. mirabilis but low simi-
larity (20-30%) with that of Shigella spp. and Salmonella
enterica subsp.
Two-component systems
Nineteen potential TCS were identified. These include the
quorum sensors qseBC (MM2889, MM2890), yedWV
(MM2314, MM2315), and BarA/UhpA of the LuxR family
(MM3087, MM1090). Nineteen orthologues that encode
TCS components were identified in P. mirabilis HI4320
[32], P. alcalifaciens NCTC 10286; r04, P. rettgeri DSM#
1131, P. rustigianii DSM# 4541, Enterobacter aerogenes
KCTC 2190, Photorhabdus luminescens laumondii TTO1,
and Y. enterocolitica 8081.
Regulation
Analysis of the M. morganii genome identified seven
sigma factor subunits of RNA polymerase. These are the
major sigma factor rpoD (s70,sA) encoded by MM1372,
and six alternative sigma factors: rpoH (s32, sH) encoded
by MM1254, rpoN (s54, sN) encoded by MM1306 to con-
trol promoters for nitrogen assimilation, rpoS (s38, sS)
encoded by MM1208 to activate stationary-phase promo-
ters, rpoE (s24, sE) encoded by MM1906 to regulate extra-
cytoplasmic stresses, rpoF (s28, sF) encoded by MM1736
to regulate flagellum-related functions, and a FecR family
sigma factor encoded by MM1954.
The small RNA regulatory gene ryhB found in E. coli
and P. mirabilis [49], which regulates a set of iron-storage
and iron-usage proteins, is present in only a single copy
(contig 25).
IgA protease
The zapA gene encodes a zinc metalloprotease that
cleaves a broad range of host proteins, including serum
and secretory IgA1, IgA2 and IgG, complement proteins,
and antimicrobial peptides [35]. Whereas the M. morganii
KT, P. mirabilis HI4320, and P. luminescens laumondii
TTO1 genomes all encode zapABCD (MM1054-MM1056,
MM1058), the P. mirabilis HI4320 genome encodes
zapEEEABCD [32].
Lipopolysaccharide and the cell capsule
Lipopolysaccharide (LPS), the main structural component
of the outer membranes of Gram-negative bacteria, con-
sists of a lipid A molecule and a variable O-antigen. Lipid
A released during bacterial lysis induces endotoxic shock.
Several O-specific polysaccharides of M. morganii have
been investigated [50,51], and at least 55 O-antigens have
been identified [52]. The genes predicted to be involved in
the synthesis of LPS and the enterobacterial common anti-
gen [53] are listed in Additional File 6: Supplementary
Figure 2 The duplicated MR/P fimbrial operons of M. morganii. The mrp operon (mrpABCDEFGHJ, solid red line region) is an important
determinant of virulence in bacteria responsible for urinary tract infections. mrpI encodes a recombinase that controls the invertible promoter
element of the mrp operon. A duplicated operon mrp’ (mrpABCCDGEFE, broken orange line) is located immediately downstream of mrpJ. The
numbers 292 through 314 represent the identifiers of M. morganii KT gene products MM0292 through MM0314. The term ‘weak’ denotes limited
homology to the paralogous pair in mrp.
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table 5. Four genes, rcsB (MM1706), rcsC (MM1707), rcsD
(MM1705), and rcsF (MM2111), are implicated in the reg-
ulation of capsule synthesis.
Immunity-like system
Clusters of regularly interspaced short palindromic repeats
consist of multiple short nucleotide repeats, which are
separated by unique spacer sequences flanked by charac-
teristic sets of CRISPR-associated genes [54,55]. The
CRISPR-associated proteins MM3304, MM3306, and
MM3307 were identified downstream of the degenerate
prophage #6. Comparison of the M. morganii genome
with that of the other 14 members of the Enterobacteria-
ceae analysed revealed orthologues in the pathogens
P. stuartii ATCC# 25827, E. coli UTI89, and E. coli APEC
O1, all of which have been implicated in causing urinary
tract infections [56].
Haemolysins
The gene hmpA, encoding a secreted haemolysin, was
originally identified in uropathogenic isolates [57,58].
The two partner genes, hmpBA, encoding secreted pro-
teins that are highly conserved in P. mirabilis [59], are
encoded by MM2452 and MM2453 in M. morganii
KT. Functional similarity of the E. coli and M. morga-
nii homologues of HmpBA was reported previously
[60].
Urease hydrolysis and putrescine production
Rapid urea hydrolysis is a prominent phenotype of Pro-
teeae organisms [61]. The urease enzyme is believed to be
a cause of urinary stone formation [62]. The urease of
M. morganii, which revealed a high degree of amino acid
conservation to P. mirabilis urease, has been purified and
characterised [4]. Ureases from both M. morganii and
P. mirabilis urease gene cluster are required for virulence
[63]. The analysis revealed that the closest homologues of
the members of the urease gene cluster ureABCEFGD
were the orthologues from Yersinia pseudotuberculosis
and Y. enterocolitica, with amino acid identities that ran-
ged from 69% to 94%. Unlike the urease gene cluster of
P. mirabilis, the M. morganii genome has a gene that
encodes the transporter MM1968, in addition to MM1961
to MM1967. On the other hand, the P. mirabilis ureR
gene, which encodes a transcriptional activator, was not
found in the genome.
The genome of M. morganii KT contains genes for
two pathways involved in putrescine production. The
first of these pathways involves ornithine decarboxylase,
which is encoded by speF (MM3013), and the putrescine
transporter, which is encoded by potE (MM3012). The
enzymes in the second pathway, which are encoded by
carAB (MM2009 and MM2010), argI (MM0127), argG
(MM1552), argH (MM1551), speA (MM2553), and speB
(MM2554), also participate in urea production. All of
the urease cluster genes that encode enzymes from both
pathways have orthologues in P. mirabilis HI4320 [32].
Toxins
Several CDSs that encode potential toxins were found.
These include a gene that encodes the cytotoxin RtxA
(MM0676), the two XaxAB genes (MM0454 and
MM0455) that encode apoptotic toxins, a putative inti-
min gene for host-cell invasion (MM0208), a HlyD-family
toxin scretion protein (MM2481), and a transporter gene
(MM2482). Among the nine insecticidal toxin-related
genes (Additional File 7: Supplementary table 6), tccB,
tccA, and tcdB2 (MM0965 through MM0967) are ortho-
logous to the insecticidal toxin genes of Pseudomonas
spp. The three other insecticidal toxin genes xptA1A1C1
(MM1780 through MM1782) were identified in a contin-
uous locus between the flagellum-related genes and che-
motaxis genes.
Ethanolamine utilisation system
The ethanolamine utilisation system, which is encoded by
the eut operon it were found to vary substantially between
species [39], is composed of the genes eutSPQTDMNEJ-
GHABCLK-pduST-eutR (MM1148 through MM1130).
This region carries two extra genes compared to the 17
eut genes found in other Enterobacteriaceae genomes [64].
In addition, the gene organisation is unique, with pduST
located between eutK and eutR. As shown in Table 6, the
sequence similarities of the three most similar proteins
ranged from 51% to 87%, and species varied.
The comparison revealed that the 17-gene operon is pre-
sent in Klebsiella pneumonia, E. coli, and Salmonella enter-
ica serovars. The pdu operon, a paralogous operon
required for use of propanediol that is found in these three
species, was not found in the M. morganii KT genome.
Located upstream of the eut operon, MM1168 through
MM1187 encode the enzymes of the cob-cbi operon,
which is required for cobalamin (vitamin B12) biosynthesis
[65-67]. Under aerobic conditions, the activity of EutBC
depends on the exogenous supply of cobalamin.
Other determinants of persistence of infection and
fitness for infection
Pathogenic bacteria produce superoxide dismutase to pro-
tect them from being killed by the reactive oxygen species
generated by their hosts [68]. As shown in Additional File
8: Supplementary table 7, the genes involved in countering
superoxide stress are katA, soxS, sodC, sodB, oxyR, and
sodA.
The pspABC operon (MM0627 through MM0629)
encodes a phage-shock-protein (psp), which ensures the
survival of E. coli during late-stationary-phase stresses
[69-71].
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Prominent virulence and fitness factors in M. morganii
KT–a comparison with Enterobacteriaceae and Proteeae
genomes
Sequence comparison between M. morganii KT and the
14 members of the Enterobacteriaceae family, including
5 Proteeae species (P. mirabilis HI4320, Providencia
stuartii ATCC# 25827, P. alcalifaciens NCTC 10286,
P. rettgeri DSM# 1131, and P. rustigianii DSM# 4541), 4
E. coli strains (O157:H7 EC4115, K-12, UTI89, and
APEC O1), K. pneumonia NTUH K2044, Enterobacter
aerogenes KCTC 2190, Photorhabdus luminescens lau-
mondii TTO1, S. enterica serovars Typhimurium LT2,
and Y. enterocolitica 8081, revealed that 459 CDSs
found in M. morganii are not found in the other Pro-
teeae species studied, and 295 CDSs found in M. morga-
nii are not found in any of the 14 Enterobacteriaceae
genomes studied (Additional file 10: Supplementary
table 9). The genes specific to M. morganii include the
genes in the eut operon, cob-cbi operon, 8 insecticidal
toxin genes, 9 T3SS genes, and 17 copies of the IS4
family transposase gene.
Among the orthologous genes, 2,411 CDSs were found
in the genomes of the 5 Proteeae species analysed, and
1,920 CDSs were found in the 14 Enterobacteriaceae gen-
omes analysed. As shown in Additional file 11: Supple-
mentary table 10, of the genomes analysed, that of
P. rettgeri is the most closely related genome to that of
M. morganii, sharing 2,802 orthologous CDSs. The ortho-
logous genes encode proteins for drug resistance, patho-
genicity (IgA protease and LPS), motility, iron acquisition,
ethanolamine use, and urease production, as well as com-
ponents of an immunity-like system (CRISPR) and fim-
brial adhesins, toxins, and haemolysin.
Discussion
Epidemiological studies have revealed that M. morganii is
frequently isolated from clinical specimens collected from
patients with nosocomial bacterial infections [3,5,11,72-74].
Strains of M. morganii that confirm the chromosomal ori-
gin of the plasmid-located cephalosporinases [17] are now
found throughout the world [75]. Genes from M. morganii
that encode cefotaxime-hydrolysing b-lactamases have also
been reported with increasing frequency [42]. Plasmid-
borne drug resistance factors have also increased the viru-
lence of M. morganii [26,27]. Gene products that confer
multidrug resistance, including metallo-b-lactamases and
efflux pumps for tetracycline, tellurite, bicyclomycin, and
kasugamycin, have been commonly reported for clinical
isolates of M. morganii. In the event of an outbreak, this
situation poses a potential threat owing to the absence of a
proper antibiotic therapy.
Compared with other members of the genus Proteeae,
which have GC contents that range from 39% to 43%, the
GC content of M. morganii is 51%. which is genetically
different from other species [76,77] and therefore
assigned to the genus Morganella [14,15,61,76]. The plas-
mid-borne gene that encodes lysine decarboxylase was
once used to classify bacteria [78,79]. However, the chro-
mosomal gene that encodes ornithine decarboxylase was
subsequently adopted as a characteristic feature to clas-
sify members of the genus Morganella [80,81].
Information on the 16S rRNA gene and paralogs in gen-
ome is important for evolution and bacterial population
studies [40]. The P. mirabilis genome has seven rRNA
operons (six 16S-23S-5S operons and one 16S-23S-5S-5S
operon) [32]. Analysis of the M. morganii KT genome
sequence revealed eight duplications of the 16S and 23S
rRNA genes while 5S rRNA were also 8. The prophage
genes that were found in the other Enterobacteriaceae spe-
cies appeared to comprise 7% of the M. morganii genome.
Interestingly, the ICEPm1 and ICE/R391 genes, which
are present in many P. mirabilis isolates [21], are not
found in strain KT. Seventeen copies of transposase genes
of the IS4 family were not present in other Proteeae gen-
omes, which implies that different transposition events
occurred during the evolution of M. morganii and of these
species.
Unlike the flagellar genes of P. mirabilis, M. morganii
KT has LysR family transcriptional regulatory genes
(MM1739 and MM1765), genes MM1743 through
MM1749 that encode the camphor resistance gene CrcB
and related proteins, a short-chain dehydrogenase/reduc-
tase SDR gene (MM1764), and the insecticidal toxin com-
plex genes xptA1A1C1 (MM1780 through MM1782).
Both M. morganii KT and P. mirabilis have duplicated
MR/P fimbrial operons, albeit with different numbers of
genes [32]. As shown in Figure 2, whereas three copies of
the MrpI recombinase gene are found in M. morganii
KT, only one copy is in the P. mirabilis genome. In
M. morganii KT, the mrp’ operon is oriented opposite to
mrpI, whereas mrpI is not present in the P. mirabilis
mrp’ operon.
More than half of the pathogenicity island genes are
conserved and found to show collinear synteny between
M. morganii and P. mirabilis. However, genes that encode
components of T3SSs have low sequence similarities.
EDTA-sensitive protease Zap gene clusters have been
found in many Proteus spp. and E. coli clinical strains but
are not produced by Providencia spp. and Morganella
spp. [37]. The zapABCD genes found in M. morganii KT
differ from those in P. mirabilis HI4320 zapEEEABCD
[32] insofar as KT has an incomplete zapE gene down-
stream of zapABCD. Although the M. morganii urease
shares a high degree of sequence similarity to P. mirabilis
ureases, the presence of the unique transporter gene
(MM1968) and the absence of ureR in M. morganii sug-
gest that the two species use different systems to regulate
urease transport.
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Although none of the insecticidal toxin genes were
found in P. mirabilis, some were found in Xenorhabdus
[82,83], Pseudomonas [84], Yersinia, and Photorhabdus
[85]. In Photorhabdus, the related toxin complex is
released upon invasion of the nematode host [86]. Why
the M. morganii clinical isolate harbours eight insectici-
dal toxin genes remains to be investigated.
The urinary and hepatobiliary tracts are two major
portals of entry for M. morganii [3]. Compared with P.
mirabilis HI4320 [32], M. morganii has fewer types of
fimbriae (three vs. five) and fewer gene clusters (8 vs.
17). This implies that M. morganii may be less virulent
than P. mirabilis in the context of urinary tract
infections.
Given that the intestine is thought to provide a rich
source of ethanolamine [39], the eut operon likely plays
a critical role in enabling M. morganii, E. coli, Klebsiella
spp., and Yersinia spp. to use ethanolamine as a source
of carbon and/or nitrogen to colonise the intestine.
However, the other Proteeae genomes lack the eut
operon and pduTS, which together encode proteins that
help to establish a microcompartment [87], and the cob-
cbi operon, which encodes the enzymes needed for
cobalamin biosynthesis.
The eut operon, which includes pduST, and the cob-
cbi operon likely provide the fitness factors required for
colonisation by intestinal bacteria. This may explain why
M. morganii is more frequently associated with nosoco-
mial bacterial infections than other members of
Proteeae.
Typically antibiotics target the essential cellular func-
tion, like cell-wall synthesis, ribosomal function, or
DNA replication [88]. The whole genome sequencing
approaches of human hosts and pathogens facilitate the
growing understanding of bacteria infectious disease
mechanisms and help to reveal crucial host-pathogen
interaction sites [89]. The pathogenicity genes allows
usage of computation approaches to identify potential
drug targets such as the conserved proteins found in
common pathogens[90]. T3SSs is highly conserved in
many disease-causing gram-negative pathogens and
hence has been used as an alternative strategy for drug
target design [90,91]. The efflux pumps which help to
get rid of toxic substances also promote biofilms, thus
making them attractive targets for antibiofilm measure
[92,93]. In many bacteria, biofilm formation, siderophore
production and adhesion activity are linked traits.
Therefore, drugs that could target bacterial adhesions
while colonization could be therapeutically useful [94].
Selective toxicity is another antibiotics approach, which
aims to have highly effective against the microbial, but
no harm to humans. The unique metabolic pathways
identified in Margonella may be considered as the new
drug targets.
Conclusions
The pathogenicity-related genes identified in the
M. morganii genome encode drug resistance determi-
nants and factors that influence virulence, such as fim-
brial adhesins, flagellar structural proteins, components
of the iron acquisition system, T3SS, and TCS, an IgA
protease, haemolysins, ureases, and insecticidal and
apoptotic toxins. Comparative analysis with 14 other
Enterobacteriaceae genomes revealed several systems
that vary between species. These include transposes of
the IS4 family, insecticidal toxins, T3SS components,
and proteins required for ethanolamine utilisation and
cobalamin biosynthesis. It is interesting to note that
neither the eut operon (which includes pduST) nor the
cob-cbi operon is found in other Proteeae genomes.
Nevertheless, the eut operon is also found in several
other non-Proteeae enterobacteria genomes, albeit with
different gene organisation.
In summary, this is the first report of an M. morganii
genome sequence. Comparative genome analysis revealed
several pathogenicity-related genes and genes not found
in other Proteeae members. The presence of the eut
operon (which includes pduST) and the cob-cbi operon in
M. morganii but not in the other Proteeae genomes stu-
died may explain why M. morganii is more frequently
associated with nosocomial bacterial infections. More-
over, the evidence that M. morganii shares features with
other non-Proteeae enterobacteria suggests that horizon-
tal gene transfer has occurred between M. morganii and
other intestinal bacteria.
Methods
Bacterial strains and culture conditions
With approval by the institutional biosafety committee,
we isolated M. morganii strain KT (year 2009) from
blood of a 57-year-old man during postoperative care.
The patient had a medical history of type 2 diabetes mel-
litus, hepatocellular carcinoma, rectal cancer and gall-
bladder stone. He was admitted for rectal cancer surgery,
and received chemotherapy and radiotherapy. Following
surgery, bacteraemia caused sepsis.
Colony morphology, Gram staining, oxidase testing (Dry
Slide; Difco Laboratories, Detroit, MI), catalase testing,
and routine biochemical reactions identified M. morganii
as the agent responsible for the infection. A presumptive
diagnosis of infection with M. morganii was confirmed
using API-20 kit reagents (Bio Merieux Vitek; Hazelwood,
Mo) and the BACTEC NR-860 apparatus (Becton Dickin-
son Diagnostic Instrument Systems, Franklin Lake, NJ).
Genomic DNA preparation
We cultured M. morganii in trypticase soy broth or on
trypticase soy agar. Bacteriological media were pur-
chased from Biostar Inc. (Taiwan).
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Genome DNA from the M. morganii strain KT was
isolated using reagents from QIAGEN DNeasy kits
(QIAGEN Inc., Valencia, CA).
Cloning and sequencing
Genome sequencing was performed using the whole
genome shotgun strategy [95]. Genomic DNA sequen-
cing reads of 101 bp pair-end reads, an average distance
between pair reads were 200 bp, and were generated
using an Illumina GA IIx (Solexa) sequencer [96].
Draft genome assembly and validation of contigs
Short sequencing reads were assembled into contigs
using ABySS version 1.2.7 software [97]. Contigs were
evaluated using the re-sequencing program SOAP2 [98],
a tool for aligning raw reads into contigs to evaluate and
validate the coverage and depths of read information for
each contigs. All contigs were aligned with short reads,
with a depth threshold of at least 300 reads.
Identification and annotation of coding sequences and
genes encoding tRNAs and rRNAs
The draft genome of M. morganii was analysed using our
own integrated annotation pipeline composed of predic-
tion and database search tools. Glimmer (version 3.02)
was used to predict assembled contig sequences for pro-
karyotic CDS regions [99]. Potential long CDSs were
extracted using the “long-orfs” program from the Glimmer
software suite. These long CDSs were then used by Glim-
mer to predict CDSs in all contigs.
We used BLAST to query non-redundant protein data-
bases with all predicted CDS regions [100] and thereby
find and validate significant protein identifications with E
value (E < 1e-5). The annotation of validate significant
protein with Clusters of Orthologous Groups functional
classification were identified from protein genbank records
[101]. The EMBOSS analysis package [102] was used to
extract and covert sequences and get predicted open read-
ing frame for further manually verified.
We used tRNAscan-SE to predict prokaryotic transfer
RNA (tRNA) genes [103]. Ribosomal 5S, 16S, and 23S
RNA (rRNA) genes predictions were performed using
RNAmmer (version 1.2) [104]. Origins of replication were
assigned based of the GC-skew analysis together with the
location of the dnaA gene and DnaA boxes of the genome,
using Ori-Finder [105]. Horizontally acquired DNA by
anomalies in the G+C content was calculating by perl pro-
gramming languages.
The previously published genome and protein sequences
of Enterobacteriaceae genomes were downloaded from the
National Center for Biotechnology Information and draft
genome and protein sequences (four Providencia spp.) of
Enterobacteriaceae genomes were downloaded from the
Genome Institute at Washington University.
We used BLAST program and formatted proteins of
other Enterobacteriaceae organisms as databases for
comparison, validate orthologous protein with E value (E
< 1e-4), identity (> 30%) and threshold to length percen-
tage of alignment.
Confirm of eut operon organisation (at eutK-pduS-pduT-
eutR order)
PCR was conducted using primer flanking ORFs: eutK-
pduS-pduT-eutR (MM1133-MM1130) (forward, TAGAG-
GACAGCCGTGATGTG; reverse, CAAACAGGGTTT
CGGTCAGT). PCRs were carried out in 25-μl reactions
containing 30 ng of genomic DNA, 1 × buffer, 250μM
deoxynucleoside triphosphate, 0.75 μl of Taq DNA poly-
merase, and 0.4 μM concentrations of forward and reverse
primers. Reactions were amplified in a thermocycler at
95°C for 2 min, followed by 30 cycles of 95°C for 15 s, 55°C
for 30 s, and 72°C for 60 s. Purified PCR products were
sequenced (ABI model 3730).
To assess if the M. morganii strain KT contained plasmids
The plasmid DNA was isolated by the procedure of alka-
line denature method [106] and then separated in 1.0%
agarose gel by gel electrophoresis. Plasmids presences
were subsequently visualised by UV exposure of the ethi-
dium bromide stained gel.
Nucleotide sequence accession number
The draft genome sequence of M. morganii KT has been
deposited in the DDBJ/EMBL/GenBank under the acces-
sion number ALJX00000000. The version described in this
paper is the first version, ALJX01000000.
Annual hospital infectious information
Information regarding bacteria responsible for clinically
relevant infections was collected over a 6-year period for
all patients diagnosed with infection by the Infectious Con-
trol Committee of Changhua Christian Hospital, a 1,600-
bed medical center in central Taiwan. The reports identi-
fied bacteria isolated from samples and their sensitivities to
the antibiotics amikacin, ampicillin, amoxicillin-clavulanate,
cefepime, cefazolin, cefuroxime, cefmetazole/flomoxef,
cefotaxime, ertapenem, gentamicin and meropenem.
Additional material
Additional File 1: Supplementary Figure 1. The origin of replication
was assigned based on the GC deviation of the genome using Ori-
Finder (*.pdf)
Additional File 2: Supplementary table 1. Resequencing analysis on
assembled contigs (*.xls)
Additional File 3: Supplementary table 2. M. morganii genes
involved in multidrug efflux genes (*.pdf)
Additional File 4: Supplementary table 3. Flagellum-related genes and
chemotaxis genes located in 58.8-kb locus of M. morganii (*.pdf)
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Additional File 5: Supplementary table 4. Protein similarity search of
Type III secretion system (T3SS) of M. morganii (*.pdf)
Additional File 6: Supplementary table 5. M. morganii genes
involved in lipopolysaccharide or enterobacterial common antigen
biosynthesis (*.pdf)
Additional File 7: Supplementary table 6. Protein similarity search of
insecticidal toxin of M. morganii (*.pdf)
Additional File 8: Supplementary table 7. M. morganii genes
involved in superoxide stress (*.pdf)
Additional File 9: Supplementary Table 8. 2 prophages and 12
degenerate prophages (*.xls)
Additional File 10: Supplementary Table 9. Specific CDSs in
M. morganii compared to other Enterobacteriaceae (n = 14) and/or
Proteeae (n = 5). (*.xls)
Additional File 11: Supplementary Table 10. Comparison of CDSs in
M. morganii compared to other Enterobacteriaceae (n = 14) and
Proteeae (n = 5). (*.xls)
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